Literature DB >> 22503065

The obesity paradox, cardiorespiratory fitness, and coronary heart disease.

Paul A McAuley1, Enrique G Artero, Xuemei Sui, Duck-chul Lee, Timothy S Church, Carl J Lavie, Jonathan N Myers, Vanesa España-Romero, Steven N Blair.   

Abstract

OBJECTIVE: To investigate associations of cardiorespiratory fitness (CRF) and different measures of adiposity with cardiovascular disease (CVD) and all-cause mortality in men with known or suspected coronary heart disease (CHD). PATIENTS AND METHODS: We analyzed data from 9563 men (mean age, 47.4 years) with documented or suspected CHD in the Aerobics Center Longitudinal Study (August 13, 1977, to December 30, 2002) using baseline body mass index (BMI) and CRF (quantified as the duration of a symptom-limited maximal treadmill exercise test). Waist circumference (WC) and percent body fat (BF) were measured using standard procedures.
RESULTS: There were 733 deaths (348 of CVD) during a mean follow-up of 13.4 years. After adjustment for age, examination year, and multiple baseline risk factors, men with low fitness had a higher risk of all-cause mortality in the BMI categories of normal weight (hazard ratio [HR], 1.60; 95% confidence interval [CI], 1.24-2.05), obese class I (HR, 1.38; 95% CI, 1.04-1.82), and obese class II/III (HR, 2.43; 95% CI, 1.55-3.80) but not overweight (HR, 1.09; 95% CI, 0.88-1.36) compared with the normal-weight and high-fitness reference group. We observed a similar pattern for WC and percent BF tertiles and for CVD mortality. Among men with high fitness, there were no significant differences in CVD and all-cause mortality risk across BMI, WC, and percent BF categories.
CONCLUSION: In men with documented or suspected CHD, CRF greatly modifies the relation of adiposity to mortality. Using adiposity to assess mortality risk in patients with CHD may be misleading unless fitness is considered.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22503065      PMCID: PMC3538467          DOI: 10.1016/j.mayocp.2012.01.013

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

1.  Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age.

Authors:  Audrey H Wu; Bertram Pitt; Stefan D Anker; John Vincent; Marjan Mujib; Ali Ahmed
Journal:  Eur J Heart Fail       Date:  2010-03-30       Impact factor: 15.534

2.  Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years.

Authors:  Paul A McAuley; Peter F Kokkinos; Ricardo B Oliveira; Brian T Emerson; Jonathan N Myers
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

3.  Impact of weight on long-term survival among patients without known coronary artery disease and a normal stress SPECT MPI.

Authors:  Seth Uretsky; Azhar Supariwala; Padmakshi Singh; Prashanth Atluri; Surinder S Khokhar; Hari K Koppuravuri; Rajeev Joshi; Anupa Mandeva; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2010-03-19       Impact factor: 5.952

4.  Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease.

Authors:  Kashish Goel; Randal J Thomas; Ray W Squires; Thais Coutinho; Jorge F Trejo-Gutierrez; Virend K Somers; John M Miles; Francisco Lopez-Jimenez
Journal:  Am Heart J       Date:  2011-03       Impact factor: 4.749

5.  Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.

Authors:  Terase Lancefield; David J Clark; Nick Andrianopoulos; Angela L Brennan; Christopher M Reid; Jennifer Johns; Melanie Freeman; Kerrie Charter; Stephen J Duffy; Andrew E Ajani; Joseph Proietto; Omar Farouque
Journal:  JACC Cardiovasc Interv       Date:  2010-06       Impact factor: 11.195

6.  The joint effects of cardiorespiratory fitness and adiposity on mortality risk in men with hypertension.

Authors:  Paul A McAuley; Xuemei Sui; Timothy S Church; James W Hardin; Jonathan N Myers; Steven N Blair
Journal:  Am J Hypertens       Date:  2009-07-16       Impact factor: 2.689

7.  The obesity paradox, weight loss, and coronary disease.

Authors:  Carl J Lavie; Richard V Milani; Surya M Artham; Dharmendrakumar A Patel; Hector O Ventura
Journal:  Am J Med       Date:  2009-08-13       Impact factor: 4.965

Review 8.  Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review.

Authors:  M Fogelholm
Journal:  Obes Rev       Date:  2009-09-09       Impact factor: 9.213

Review 9.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.

Authors:  Carl J Lavie; Richard V Milani; Hector O Ventura
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

10.  Cardiorespiratory fitness and adiposity as mortality predictors in older adults.

Authors:  Xuemei Sui; Michael J LaMonte; James N Laditka; James W Hardin; Nancy Chase; Steven P Hooker; Steven N Blair
Journal:  JAMA       Date:  2007-12-05       Impact factor: 56.272

View more
  55 in total

1.  The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

Authors:  R Padwal; F A McAlister; J J V McMurray; M R Cowie; M Rich; S Pocock; K Swedberg; A Maggioni; G Gamble; C Ariti; N Earle; G Whalley; K K Poppe; R N Doughty; A Bayes-Genis
Journal:  Int J Obes (Lond)       Date:  2013-10-31       Impact factor: 5.095

2.  Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer.

Authors:  Benjamin A Kuritzkes; Emmanouil P Pappou; Ravi P Kiran; Onur Baser; Liqiong Fan; Xiaotao Guo; Binsheng Zhao; Stuart Bentley-Hibbert
Journal:  Int J Colorectal Dis       Date:  2018-04-15       Impact factor: 2.571

Review 3.  Use of anthropometry for the prediction of regional body tissue distribution in adults: benefits and limitations in clinical practice.

Authors:  Aldo Scafoglieri; Jan Pieter Clarys; Erik Cattrysse; Ivan Bautmans
Journal:  Aging Dis       Date:  2013-12-15       Impact factor: 6.745

4.  Exercise-induced differential changes in gene expression among arterioles of skeletal muscles of obese rats.

Authors:  M Harold Laughlin; Jaume Padilla; Nathan T Jenkins; Pamela K Thorne; Jeffrey S Martin; R Scott Rector; Sadia Akter; J Wade Davis
Journal:  J Appl Physiol (1985)       Date:  2015-07-16

5.  Letters to the Editor.

Authors:  Tarik Akar; Gökhan Dindar
Journal:  Ochsner J       Date:  2015

Review 6.  [Obesity in the COVID era: A global health challenge].

Authors:  Miguel A Rubio Herrera; Irene Bretón Lesmes
Journal:  Endocrinol Diabetes Nutr       Date:  2020-10-21

Review 7.  Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention.

Authors:  Damon L Swift; Carl J Lavie; Neil M Johannsen; Ross Arena; Conrad P Earnest; James H O'Keefe; Richard V Milani; Steven N Blair; Timothy S Church
Journal:  Circ J       Date:  2013-01-18       Impact factor: 2.993

8.  Partnership Processes to Develop SHE Tribe: A Healthy Lifestyle Intervention.

Authors:  Leilani Dodgen; Emily Spence-Almaguer; Katherine Cantu Anguiano; Alison Hooker; Sonia White
Journal:  Health Promot Pract       Date:  2018-11-20

9.  Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.

Authors:  Carl J Lavie; Lawrence P Cahalin; Paul Chase; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Daniel E Forman; Marco Guazzi; Ross Arena
Journal:  Mayo Clin Proc       Date:  2013-02-27       Impact factor: 7.616

10.  Presence of obesity is associated with lower mortality in elderly patients with implantable cardioverter defibrillator.

Authors:  A Jahangir; M Mirza; M Shahreyar; T Mengesha; R Shearer; S Sultan; A Jahangir; I Choudhuri; V Nangia; A Dhala; A Bhatia; I Niazi; J Sra; A J Tajik
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.